Introduction {#s1}
============

*Bacillus anthracis* is a Gram-positive bacterium, either aerobic or facultative anaerobic. It is the causative agent of anthrax, and has been reported as a potential bioterrorism weapon due to its dormant spores that can survive with high stability and low mortality in nutritive conditions and other severe environments[@pone.0057959-Hanna1]. Anthrax infection occurs via introduction of *B.anthracis* spores into a skin abrasion, inhalation, or ingestion [@pone.0057959-Blendon1]. Inhalation anthrax is the most severe form of the disease and is initiated by uptake of infective spores by alveolar macrophages. The ingested spores germinate into vegetative bacilli that invade the bloodstream, where they multiply massively and express toxins and virulence factors. If not treated by prompt antibiotic administration, the disease results in death of the infected organism, as a consequence of toxemia and bacteremia[@pone.0057959-Blendon1]. At the same time, the protective antigen (PA) and some other unknown immunogenic proteins of the *Bacillus anthracis* are able to elicit a humoral immune response in the course of bacterial infections.

Fully virulent forms of *B.anthracis* carry two large plasmids: pXO1 and pXO2, which are involved in toxin production and capsule formation, respectively. Several studies have shown that strains with only one plasmid are attenuated in animal hosts. The tripartite toxin, the protective antigen (PA), lethal factor (LF) and edema factor (EF), are encoded by the genes *pagA, lef*, and *cya* on pXO1, respectively. PA has no toxic effect itself, but it plays an essential role in recognizing and binding a membrane receptor on the surface of target cells [@pone.0057959-Bradley1], [@pone.0057959-Buchmeier1] and generating the portal that mediates the entry of EF and LF into the cells, where their detrimental effects occur. All of these are associated with *B.anthracis* pathogenicity.

Although early treatment with antibiotics such as penicillin, doxycycline or ciprofloxacin can halt progression of infection, vaccination remains the preferred method for prevention of infection and eradication of the causative agent. The currently used anthrax vaccines in the United States (Anthrax Vaccine Adsorbed; AVA) and United Kingdom (Anthrax Vaccine Precipitated; AVP) are component vaccines that are based on culture filtrates of avirulent *B.anthracis* strains lacking the pXO2 plasmid[@pone.0057959-Hambleton1], [@pone.0057959-Turnbull1]. These pXO1-containing strains produce large amounts of PA, which is the major component of each vaccine. Although the efficacy and safety of both vaccines have been established, there are concerns over side effects. These may be caused by residual enzymatic components in the filtrate, which combine with PA to form active toxin complexes[@pone.0057959-Turnbull1]. Some recipients probably also develop hypersensitivity to unidentified components of the vaccine. It is possible that other factors in the vaccine including the aluminum adjuvant and preservatives may be responsible for adverse clinical symptoms. However, the Russian(STI-1) and Chinese (A16R; used in this study) anthrax vaccines utilize a live attenuated PA-producing form of *B.anthracis* spores that cannot produce capsule because of lose of the capsule-coding plasmid pXO2[@pone.0057959-Shlyakhov1], [@pone.0057959-Dong1]. Although the live spore anthrax vaccines have been reported to have greater efficacy than the AVA or AVP vaccine [@pone.0057959-Friedlander1], due to their high reactogenicity, such live vaccines are suitable only for veterinary purposes in Western countries. Several studies have shown that this higher protective efficacy of the spore-base vaccine is due to the contribution of unidentified spore antigens that can augment the protective efficacy of PA-based vaccines [@pone.0057959-Welkos1], [@pone.0057959-Cohen1], [@pone.0057959-Brossier1]. Thus, it is rational that combining PA with one or some of the spore immunogenic proteins in a formulation may ultimately lead to a highly efficacious and safer vaccine.

Immunoproteomics is a science combining proteomics and immunology that facilitates screening many immunogenic proteins simultaneously[@pone.0057959-Drake1], [@pone.0057959-Klade1]. The spores are crucial to infection and persistence of *B.anthracis*, and the spores and vegetative cells can elicit a humoral immune response in the course of bacterial infections. Therefore we used the spore and the vegetative form of the *B.anthracis* vaccine strain A16R to identify immunogenic proteins that might augment the protective efficacy of PA-based vaccines. Our analysis revealed a list of conserved antigenic spore proteins and vegetative proteins of *B.anthracis* that may be potential candidates in the future for therapeutics and vaccines development. Some of these immunogenic proteins might be tested as novel vaccine candidates themselves or utilized for enhancing the protective efficacy of the vaccine available. Future work probing the identified immunogenic proteins with the serum of convalescent anthrax patients and *in vivo* protection experiments should be carried out to validate the immunogenicity and protective efficacy.

Materials and Methods {#s2}
=====================

Bacterial strain and growth conditions {#s2a}
--------------------------------------

The attenuated vaccine strain A16R (pXO1^+^, pXO2^−^) of *B.anthracis* was used in this study. A16R vaccine was derived from a wild *B.anthracis* strain A16, which was isolated from a mule carcass that died of anthrax in the city of LangFang, Hebei province in 1953, by exposure to ultraviolet radiation, which resulted in lose of the capsule-coding plasmid pXO2. Cells were grown under the aerobic conditions in Brain Heart Infusion (BHI) or Luria--Bertani (LB) liquid medium at 37°C with vigorous agitation. *Escherichia coli* strains DH5α and BL21 used for prokaryotic expression were grown in LB agar or LB broth (Difco). Ampicillin was added at a concentration of 100 µg/ml.

Preparation of live spores of *B.anthracis strain A16R* {#s2b}
-------------------------------------------------------

The spores were isolated as described previously, with some modifications [@pone.0057959-Dixon1], [@pone.0057959-Sylvestre1]. *B.anthracis* was cultured first in BHI liquid medium overnight and then spread onto LB agar plates for several days until 95% of the spores formed. The spores were confirmed by spore staining and resuspended in distilled water. Spore suspensions were heated first at 45--48°C for 16--18 h to disrupt the vegetative cells, then 65°C for 1 h to kill any viable vegetative cells, washed extensively with ice-cold sterile 10% glycerol prepared in deionized water to remove the vegetative cells and debris, and resuspended in sterile deionized water. Gradient dilution was used to count the number of purified spores. The harvested spores were stored at −20°C for 1 week to 30 months.

Preparation of rabbit immune serum against *B.anthracis* live spores {#s2c}
--------------------------------------------------------------------

Serum preparation for 2D western blotting was as described previously [@pone.0057959-Gat1]. Four New Zealand white rabbits were used. All animal experiments were approved by our Institution Animal Care and Use Committee (Beijing Institute of Biotechnology) and all experiments were done in accordance with the ethical guidelines of our Institution. Specific pathogen-free New Zealand white rabbits were purchased from Beijing Laboratory Animal Center (Beijing, China) and housed in pathogen free conditions. Serum was collected following multiple injections of live spores of *B.anthracis* A16R (pXO1^+^, pXO2^−^), gradually increasing the dosage from 10^5^ to 10^8^ CFU/ml, after 2 weeks for the first time, followed by 1-week intervals for the next three times. The first challenge was inguinal injection with 1 ml 10^5^ CFU/ml spores. The second challenge was intravenous injection with 1 ml 10^6^ CFU/ml spores. The third challenge was intravenous injection with 1 ml 10^7^ CFU/ml spores. The fourth challenge was subcutaneous injection with 1 ml 10^8^ CFU/ml spores. The sera were evaluated for the presence of antibody against total vegetative proteins by ELISA, using PA-D4 protein (domain 4 of PA, representing the 139 amino acids of the carboxyl terminal, which contains the host cell receptor binding site and the dominant protective epitodes of PA) as the coating antigen as described previously [@pone.0057959-Yan1]. The antibody titer was 1∶12600.

2D gel electrophoresis (2-DE) and western blot analysis {#s2d}
-------------------------------------------------------

### Extraction of spore and vegetative proteins for 2-DE {#s2d1}

The spore proteins extraction method was adapted from several previously reported protocols [@pone.0057959-Liu1], [@pone.0057959-Redmond1]. Spores collected above were washed four times for 10 min at 8000 rpm with low-salt washing buffer (3 mM KCl, 1.5 mM KH~2~PO~4~, 68 mM NaCl, 9 mM NaH~2~PO~4~) and then resuspended in 1 ml lysis buffer containing ZOOM 2D protein solubilizing buffer-1 (Invitrogen, Carlsbad, CA, USA) and Protease Inhibitor Cocktail (Roche, Indianapolis, IN, USA). The samples were pulse sonicated for 10 min (pulse on 2 s, pulse off 6 s), followed by addition of the sample buffer (1 µl pH 3--10 IPG buffer and 1 U DNase-1 and 3 U RNase), incubated at room temperature for 30 min to eliminate DNA and RNA contamination, and centrifuged for 30 min at 20 000 rpm at 18°C to sediment the insoluble components. The supernatant was collected, and its protein concentration was determined using a PlusOne 2-D Quant Kit (GE Healthcare, Piscataway, NJ, USA), and 0.8-mg aliquots were stored at −70°C until use.

The vegetative cells of A16R were harvested when cultured for 23 h. Preparation of the whole cellular protein was performed as described previously [@pone.0057959-Gorg1]. Cells were grown aerobically in 50 ml BHI broth at 37°C for 23 h. Cells were harvested and centrifuged for 10 min at 8000 rpm (Sigma 3K12, St Louis, MO, USA) at 4°C, and the pellet was washed four times for 10 min at 8000 rpm with low-salt washing buffer. The pellet was resuspended in 5 ml lysis buffer containing ZOOM 2D protein solubilizing buffer-1 (Invitrogen) and Protease Inhibitor Cocktail (Roche), and ruptured by sonication for 15 min at 0°C. After adding 2.5 mg RNaseA, 100 U RQ1 DNase and 50 µl IPG buffer (pH 3--10), the lysed cell suspension was kept at room temperature for 1 h to solubilize proteins efficiently, and centrifuged for 20 min at 20 000 rpm to sediment the insoluble components. The supernatant was collected, and its protein concentration was determined using a PlusOne 2-D Quant Kit (GE Healthcare), and 0.8-mg aliquots were stored at −70°C until use.

### 2-DE separation of spore and vegetative proteins {#s2d2}

To achieve better separation, pH 4--7, 3.9--5.1, 4.7--5.9 and 5--6 Immobilized pH Gradient (IPG) strips (18 cm; GE Healthcare) were used in the isoelectric focusing analysis. One aliquot (0.8 mg) protein sample was treated first with the 2-D Clean-Up kit (GE Healthcare), and then resuspended in 350 µl rehydration buffer \[7 M urea, 2 M thiourea, 4% (w/v) CHAPS, 50 mM DTT, 0.5% IPG Buffer (same pH range of the IPG strip)\]. Proteins were subjected to proteome analysis by 2-DE as described previously, with modifications[@pone.0057959-Gorg1], [@pone.0057959-Shin1]. The sample was used to rehydrate an 18-cm IPG strip for 12 h at 20°C. The following focusing parameters were applied: 1 h 300 V; 1 h 600 V; 1 h 1000 V; 1 h 8000 V; followed by the 8000 V holding step at the end of the run (64000 V·h total). After focusing was completed, IPG strips were equilibrated with 1% (w/v) DTT in equilibration base buffer \[50 mM Tris--HCl (pH 8.8), 6 M urea, 30% glycerol, 2% SDS, 0.01% bromophenol blue\] for 15 min, followed by another equilibration with 2.5% (w/v) iodeacetamide in the same buffer for 15 min. Equilibrated IPG strips were placed onto 12.5% SDS-polyacrylamide gels for the second dimensional separation. Electrophoresis gels were stained with Coomassie blue [@pone.0057959-Cordwell1] and image analysis was performed with Image-Master 2D Elite Version 3.1. Two replicate 2-DE gels for each sample were used: one for Coomassie blue stain and the other for western blot analysis. To insure reproducible results, at least three spore/vegetative preparations were used for the 2D gel electrophoresis (2-DE) analysis.

### 2-DE immunoblot assays using rabbit immune sera against *B.anthracis* live spores {#s2d3}

Immunoblotting was conducted as described previously[@pone.0057959-Wu1]. For western blotting, proteins on one copy 2D gels were transferred to polyvinylidene difluoride (PVDF)(Millipore,Billerica, MA, USA) membranes using transferring buffer (25 mM Trizma base, 190 mM glycine, 20% methanol) at 100 V for 90 min. After the transfer, the PVDF membrane was blocked with 5% skimmed milk prepared in PBS with 0.05% Tween 20 (PBS-T) overnight at 4°C and incubated with the anti-*B.anthracis* serum prepared above, at a dilution of 1∶2000 for 4 h at room temperature. Membranes were then washed four times with PBS-T for 20 min, developed using an Enhanced Chemiluminescence (ECL) kit (Thermo scientific, Rockford, IL, USA), and exposed to X-ray film (Kodak, Wuxi, China) for visualization of the antigenic proteins. For controls, corresponding antisera from unimmunized rabbits were collected and used for 2-DE immunoblotting. All immunogenic proteins that appeared in both the control and treated blots were excluded from the list of immunogenic candidate proteins.

### In-gel trypsin digestion and matrix-assisted laser desorption ionization time-of-flight/time-of-flight mass spectrometry (MALDI-TOF/TOF MS) {#s2d4}

2-DE gels and their immunoblot profiles were compared. The Coomassie-stained protein spots corresponding to the immunoreactive spots in western blotting were cut out, and in-gel protein digestion was performed as described previously [@pone.0057959-Wang1]. Peptides from digested proteins were solubilized in 2 µl 0.5% trifluoroacetic acid. Tryptic peptides were subjected to MALDI-TOF/TOF MS. All MALDI-TOF/TOF MS measurements were performed on a Bruker UltraReflex™ III MALDI-TOF/TOF mass spectrometer (Bruker Daltonics, Karlsruhe, Germany) operated in reflection mode. Peptide mass fingerprints were analyzed and searched against the theoretical spectra of *B.anthracis* strain Ames (5311 entries, including all of the ORFs predicted on the chromosome of *B.anthracis* str. Ames; accession number NC_003997) and Sterne (5287 entries, including all of the ORFs predicted on the chromosome of *B.anthracis* str. Stern; accession number NC_005945) using the Mascot Daemon software package (Matrix Science Ltd.). The search parameters were as follows: trypsin digestion with one missed cleavage; carbamidomethyl modification of cysteine as a fixed modification and oxidation of methionine as a variable modification; peptide tolerance maximum, ±0.2 Da; MS/MS tolerance maximum, ±0.6 Da; peptide charge, 1+; monoisotopic mass. Scores \>49 was significant (*p*\<0.05) for a local peptide mass fingerprinting (PMF) search. For unambiguous identification of proteins, more than five peptides must be matched for a PMF search.

Validation of immunogenicity of proteins identified by immunoproteomics {#s2e}
-----------------------------------------------------------------------

To validate the immunogenicity of the identified proteins, 12 were selected for expression and purification. On the one hand, the purified proteins were probed with the rabbit immune sera against live spores of the *B.anthracis* vaccine strain A16R. On the other hand, the purified proteins were used to immunize mice and the antisera were prepared. These immune sera against each of the 12 proteins were used to probe the whole cell lysate proteins of the A16R vaccine.

### Proteins expression and purification {#s2e1}

Twelve proteins were chosen for prokaryotic expression: two of which (BA0887 and BA3338) were S-layer homology domain proteins and the other 10 were all enzymes. The two categories of proteins were previously thought to be potential immunogens[@pone.0057959-Ariel1]. The primer pairs used to amplify the DNA fragments of the recombination proteins are listed in [Table S1](#pone.0057959.s001){ref-type="supplementary-material"}. The gene fragment was PCR amplified, restriction enzyme digested, and linked to the expression vector pET32a. The cloned gene and part of the vector fragment flanking the cloned gene were sequenced to confirm the right reading frame. The recombinant plasmid was transformed into *Escherichia coli* strain BL21. For expression of the recombinant proteins, the cells were induced by adding 1 mM IPTG when they grew to OD~600~ = 0.6--1.0, and harvested after 16 h at 16°C. The soluble recombinant proteins were identified by western blotting using the His-horseradish peroxidase (HRP) antibody and purified on a Ni^2+^ Sepharose column with gradient elution.

### The purified proteins were probed with rabbit anti-live spore immune sera {#s2e2}

Twelve purified proteins were electrophoresed, and the gels were then transferred to PVDF membranes (Millipore, Billerica, MA, USA) at a constant voltage of 15 V for 1 h 45 min. The transferred membranes were blocked with TBS-T (TBS with 0.05% Tween 20) containing 5% skimmed milk. The membrane was incubated for 60 min with rabbit anti-live spore immune sera (diluted to 1∶500 in TBS-T) and washed with TBST three times for 7 min. Membranes were incubated in 40 ml goat anti-rabbit IgG-HRP (Thermo Scientific, Rockford, IL, USA) regents for 60 min at room temperature and washed by TBS-T four times for 7 min. Membranes were dipped into ECL substrate solutions (Thermo Scientific) for 5 minutes and then exposed on the film (Kodak, Wuxi, China).

### Preparation of mouse immune serum against fusion proteins {#s2e3}

To generate polyclonal antibodies against the fusion protein, 100 µg of the purified recombination protein with Freund\'s incomplete adjuvant (Sigma) was injected into five female BALB/c mice by subcutaneous and intraperitoneal injection. The mice were boosted another two times at 2-week intervals with 100 µg purified protein mixed with Freund\'s incomplete adjuvant (Sigma). The titers of the sera were measured by indirect ELISA 7 days after the last boost, and the sera were used for immunoblotting experiments. For controls, corresponding antisera from unimmunized mice were collected.

### Western blotting with A16R whole cell lysate proteins {#s2e4}

About 1 ml of the vegetative cells of A16R cultured for 23 h were harvested, boiled and centrifuged and 20 µl supernatant was loaded onto 12% acrylamide gels for SDS-PAGE, and transferred to PVDF membranes (Millipore). The membranes were blocked with 5% BSA and then incubated for 1 h with the mouse control serum and mouse immune sera raised against recombinant proteins. The membranes were washed and HRP-conjugated goat anti-mouse IgG secondary antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were added for 1 h. The ECL Plus Kit (Pierce, Rockford, IL, USA) was used for detection. For controls, corresponding antisera from unimmunized mice were collected and subjected to western blotting with A16R whole cell lysate proteins.

Computational analyses of the novel identified immunogenic protein {#s2f}
------------------------------------------------------------------

Analyses of protein domains were carried out by searching against the Pfam and SMART databases with the online program InterPro Scan (<http://expasy.org/tools>). The subcellular localization predictions were carried out with the PSORTb online program (<http://www.psort.org/psortb/index.html>). Predictions of presence and location of signal peptides in the N-terminal 70aa of the protein were carried out with the online program SignalP (<http://www.cbs.dtu.dk/services/SignalP/>). Predictions of transmembrane regions and orientation of the proteins were carried out using the online program TMpred (<http://www.ch.embnet.org/software/TMPRED_form.html>). The functional assignments were carried out by comparing the amino acid sequences of the interest proteins with the COGs (Clusters of Orthologous Groups of proteins) database using the online program COGNITOR (<http://www.ncbi.nlm.nih.gov/COG/old/xognitor.html>).

Results {#s3}
=======

Staining and counting *B.anthracis* spores {#s3a}
------------------------------------------

Basic fuchsin and methylene blue staining was carried out to observe the purity of the collected spores. A large number of spores stained red were observed by light microscopy. It was concluded that the spores harvested could be used as the antigen to immunize the rabbits. The pure spores were treated with gradient dilution and plated on BHI agar for counting. The concentration of the spores was 5.5×10^9^ CFU/ml.

Identify of immunogenic spore and vegetative proteins by immunoproteomics {#s3b}
-------------------------------------------------------------------------

2-DE immunoblotting was performed to investigate the immunogenic proteins using rabbit immune sera against *B.anthracis* live spores. In the 2-DE map of the vegetative proteins, 106 spots were cut and 70 spots representing 45 proteins were successfully identified by MALDI-TOF/TOF MS, while 25 protein spots were cut and 13 spots representing 11 proteins were successfully identified in the spore proteins ([Fig. 1](#pone-0057959-g001){ref-type="fig"}). The MALDI-TOF/TOF MS results are illustrated in the supplemental material ([Tables S2](#pone.0057959.s002){ref-type="supplementary-material"} and [S3](#pone.0057959.s003){ref-type="supplementary-material"}). There were six proteins identified both in vegetative and spore proteins. Twenty-four proteins had been reported previously ([Table 1](#pone-0057959-t001){ref-type="table"}).

![2-DE map and corresponding western blotting image of *B.anthracis* A16R vegetative and spore proteins.\
(A--C) Vegetative proteins for the pH 3.9--5.1, 4.7--5.9 and 5--6 strips, respectively. (D) Spore proteins for the pH 4--7 strip. (E and F) Vegetative and spore proteins for the pH 4--7 strips, respectively. (a and b) for A--D indicate 2-DE maps and the corresponding western blotting images using rabbit immune sera against *B.anthracis* live spores, respectively. (a and b) for E and F indicate 2-DE maps and the corresponding western blotting images using rabbit unimmunized sera, respectively. The spots whose names are in boxes indicate that those proteins were identified in both vegetative and spore proteins. The same upper case letter indicates the same protein in the vegetative and spore proteins.](pone.0057959.g001){#pone-0057959-g001}

10.1371/journal.pone.0057959.t001

###### Immunogenic proteins identified in this study.

![](pone.0057959.t001){#pone-0057959-t001-1}

  Vegetative immunoreactive spots                                                       Spore immunoreactive spots   Accession No.    gene                                                   Protein description                                                  MW^a^   pI[b](#nt102){ref-type="table-fn"}                                                                                                                       Note
  ------------------------------------------------------------------------------------ ---------------------------- --------------- -------- ------------------------------------------------------------------------------------------------------------------- ------- ------------------------------------ -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  r028                                                                                              \-                  BA0080         \-                                    Negative regulator of genetic competence clpC/mecB                                   90532                  6.06                                                                                                                            [@pone.0057959-Chitlaru1]
  r161                                                                                             r189                 BA0108        tuf                                                   elongation factor Tu                                                  43026                  4.93                                                                                              [@pone.0057959-Mukhopadhyay1], [@pone.0057959-Delvecchio1], [@pone.0057959-Chitlaru1]
  r099\\r100\\r101                                                                                 r196                 BA0267       groEL                                                    chaperonin GroEL                                                    57396                  4.79                                                                                              [@pone.0057959-Mukhopadhyay1], [@pone.0057959-Delvecchio1], [@pone.0057959-Chitlaru1]
  r066\\r073\\r096                                                                                  \-                  BA0309         \-                                          1-pyrroline-5-carboxylase dehydrogenase                                        56418                  5.43                                                                                                                            [@pone.0057959-Chitlaru1]
  r094\\r095                                                                                        \-                  BA0345        ahpC                                         alkyl hydroperoxide reductase, subunitC                                        20878                  4.81                                                                                                                            [@pone.0057959-Chitlaru1]
  r012\\r015\\r016\\r018\\r030\\r031\\r034\\r035\\r037\\r048\\r052\\r063\\r075\\r142                \-                  BA0887        eag                                                    S-layer protein EA1                                                  91307                  5.7                   [@pone.0057959-Ariel1], [@pone.0057959-Fouet1], [@pone.0057959-Mesnage1], [@pone.0057959-Mukhopadhyay1], [@pone.0057959-Mesnage2], [@pone.0057959-Mesnage3], [@pone.0057959-Fedhila1], [@pone.0057959-Delvecchio1], [@pone.0057959-Chitlaru1]
  r007                                                                                                                  BA1300        potD                                               putrescine-binding protein                                               39552                  5.97                                                                                                                          [@pone.0057959-Mukhopadhyay1]
  r049                                                                                                                  BA1419       ilvC-1                                              Ketol-acid reductoisomerase                                              36784                  5.17                                                                                                                              [@pone.0057959-Wang1]
  r044                                                                                             r181                 BA3964        tsf                                             translation elongation factor Ts                                            32529                  5.25                                                                                                           [@pone.0057959-Mukhopadhyay1], [@pone.0057959-Delvecchio1]
  \-                                                                                               r187                 BA4184        pdhA                                    Pyruvate dehydrogenase E1 component subunit alpha                                   41415                  5.52                                                                                                                           [@pone.0057959-Delvecchio1]
  r001\\r002                                                                                       r176                 BA4499       sodA-1                                                 Superoxide dismutase                                                  22650                  5.3                                                                                                                              [@pone.0057959-Ariel1]
  r097\\r098                                                                                       r198                 BA4539        dnaK                                                molecular chaperone DnaK                                                65784                  4.65                                                                                                            [@pone.0057959-Mukhopadhyay1], [@pone.0057959-Chitlaru1]
  r129                                                                                              \-                  BA4705        tiG                                                      trigger factor                                                     47185                  4.53                                                                                                                           [@pone.0057959-Delvecchio1]
  r132\\r133                                                                                        \-                  BA5364        eno                                                          enolase                                                        46446                  4.66                                                                                     [@pone.0057959-Shin2], [@pone.0057959-Delvecchio1], [@pone.0057959-Whiting1], [@pone.0057959-Chitlaru1]
  r009                                                                                          r183\\r184              BA5369       gap-2                                        glyceraldehyde-3-phosphate dehydrogenase                                        35974                  5.37                                                                                                               [@pone.0057959-Shin2], [@pone.0057959-Delvecchio1]
  r005                                                                                              \-                  BA5565         \-                                                hypothetical protein BA5565                                              22274                  5.45                                                                                                                              [@pone.0057959-Wang1]
  r081\\r147                                                                                        \-                  BA5580       fba-2                                             fructose bisphosphate aldolase                                             30825                  5.06                                                                                                                              [@pone.0057959-Shin2]
  r151                                                                                              \-                  BA3338         \-                                                 S-layer protein, putative                                               40427                  5.84                                                                                                                [@pone.0057959-Ariel1], [@pone.0057959-Chitlaru1]
  r054                                                                                              \-                  BA4873       ald-2                                                  Alanine dehydrogenase                                                 40141                  5.22                                                                                                                            [@pone.0057959-Chitlaru1]
  \-                                                                                               r178                 BA1021         \-                                              hypothetical protein BALH_0915                                             31558                  6.01                                                                                                                           [@pone.0057959-Delvecchio1]
  r006                                                                                              \-                  BA5588         \-                                            3-hydroxybutyryl-CoA dehydrogenase                                           31533                  5.45                                                                                                                           [@pone.0057959-Delvecchio1]
  r024                                                                                              \-                  BA2958         \-                                           3-deoxy-7-phosphoheptulonate synthase                                         40115                  5.65                                                                                                                           [@pone.0057959-Delvecchio1]
  r154                                                                                              \-                  BA1998        nadE                                            NH(3)-dependent NAD(+) synthetase                                           30083                  4.94                                                                                                                           [@pone.0057959-Delvecchio1]
  r014                                                                                              \-                  BA5061         \-                                                   hypothetical protein                                                  25273                  5.8                                                                                                                            [@pone.0057959-Delvecchio1]
  \-                                                                                            r205\\r206              BA5017        metK                                             S-adenosylmethionine synthetase                                            43464                  5.2                                                                                                                                        New
  \-                                                                                               r203                 BA5147        glyS                                                 glycyl-tRNA synthetase                                                 53497                  5.09                                                                                                                                       New
  \-                                                                                               r179                 BA1232        fabI                                         enoyl-(acyl carrier protein) reductase                                         27894                  5.45                                                                                                                                       New
  r153                                                                                              \-                  BA0347         \-                                             NH(3)-dependent NAD(+) synthetase                                           38454                  4.99                                                                                                                                       New
  r149                                                                                              \-                  BA4861       pepQ-2                             proline dipeptidase;Peptidase M24, methionine aminopeptidase                              40862                  5.13                                                                                                                                       New
  r148                                                                                              \-                  BA1497        resD    DNA-binding response regulator ResD;Signal transduction response regulator, receiver domain;CheY-like superfamily   27514                  5.08                                                                                                                                       New
  r103                                                                                              \-                  BA0344        ahpF                                        alkyl hydroperoxide reductase, F subunit                                        55061                  4.93                                                                                                                                       New
  r090                                                                                              \-                  BA2013        dpS                      general stress protein;DNA-binding protein Dps;Ferritin-like protein, Dps type                     16638                  4.79                                                                                                                                       New
  r089                                                                                              \-                  BA5290         \-                    general stress protein 20U;DNA-binding protein Dps;Ferritin-like protein, Dps type                   16899                  4.76                                                                                                                                       New
  r087                                                                                              \-                  BA0100        rplL                                              50S ribosomal protein L7/L12                                              12510                  4.71                                                                                                                                       New
  r072                                                                                              \-                  BA1555        dapB                                              dihydrodipicolinate reductase                                             29294                  5.36                                                                                                                                       New
  r070                                                                                              \-                  BA1536         \-                                               nucleoside diphosphate kinase                                             16590                  5.24                                                                                                                                       New
  r069                                                                                              \-                  BA0346         \-                                                 5-Methylthioribose kinas                                                47360                  5.38                                                                                                                                       New
  r067                                                                                              \-                  BA2354       mmsA-1                                     methylmalonic acid semialdehyde dehydrogenase                                     53169                  5.44                                                                                                                                       New
  r065                                                                                              \-                  BA1969        thrC                                                   threonine synthase                                                   37723                  5.32                                                                                                                                       New
  r057                                                                                              \-                  BA4274        nagA                                       N-acetylglucosamine-6-phosphate deacetylase                                      41642                  5.26                                                                                                                                       New
  r055                                                                                              \-                  BA4888        ackA                                                acetate/propionate kinase                                               43234                  5.25                                                                                                                                       New
  r050\\r135                                                                                        \-                  BA0079         \-                                arginine or creatine kinase;ATP guanido phosphotransferase                               40238                  5.24                                                                                                                                       New
  r038                                                                                              \-                  BA4385       bfmbC                                             dihydrolipoamide dehydrogenase                                             50914                  5.53                                                                                                                                       New
  r036                                                                                              \-                  BA0550        prkA                                             probable serine protein kinase                                             73341                  5.65                                                                                                                                       New
  r019                                                                                              \-                  BA1511        gdhA                                  glutamate/phenylalanine/leucine/valine dehydrogenase                                  47748                  5.85                                                                                                                                       New
  r017\\r136\\r150                                                                                  \-                  BA0509        pfl                                                 formate acetyltransferase                                               84712                  5.65                                                                                                                                       New
  r013                                                                                              \-                  BA2551         \-                                                    enoyl-CoA hydratase                                                  28559                  5.69                                                                                                                                       New
  r011                                                                                              \-                  BA0894         \-                                                    enoyl-CoA hydratase                                                  28746                  5.66                                                                                                                                       New
  r008                                                                                              \-                  BA4839        citZ                                                    Citrate synthase                                                    41928                  5.36                                                                                                                                       New
  r003                                                                                              \-                  BA4194         \-                              2,3,4,5-tetrahydropyridine-2-carboxylate N-succinyltransferase                             25745                  5.42                                                                                                                                       New

Note: ^a^:Molecular Weight

:Isoelectric Point

Cellular function analysis of the immunogenic proteins {#s3c}
------------------------------------------------------

[Fig. 2](#pone-0057959-g002){ref-type="fig"} shows the cellular functions of the identified immunogenic proteins from *B.anthracis* vaccine strain A16R vegetative cells and spores. The majority of the vegetative proteins were involved in amino acid transport and metabolism, energy production and conversion, post-translational modification, protein turnover, and as chaperones ([Fig. 2A](#pone-0057959-g002){ref-type="fig"}). Some of the spore proteins were involved in translation and post-translational modification, protein turnover, and as chaperones ([Fig. 2B](#pone-0057959-g002){ref-type="fig"}).

![Graphic representation of the immunogenic proteins categorized according to cellular function.\
(A) *B.anthracis* vaccine strain A16R vegetative proteins; (B) *B.anthracis* vaccine strain A16R spore proteins.](pone.0057959.g002){#pone-0057959-g002}

Validation of immunogenicity of proteins identified by immunoproteomics {#s3d}
-----------------------------------------------------------------------

To verify the immunogenicity of the candidate proteins, 12 proteins were selected for amplification and were linked to the expression plasmid pET32a. Cells were harvested before and after induction by IPTG, and the samples were separated by electrophoresis and transferred onto PVDF membranes. The His-tagged monoclonal antibody (HRP-conjugated) was used for western blotting, and the results revealed that all the expressed proteins had their corresponding theoretical molecular weight ([Fig. 3](#pone-0057959-g003){ref-type="fig"}). These recombination proteins were purified by Ni^2+^ Sepharose column chromatography and used as the antigen to obtain mouse polyclonal antibodies or to react with rabbit immune sera against live spores of *B.anthracis*.

![Expression of the 12 immunoproteins.\
The left panels are the SDS-PAGE maps and the right panels are the western blot assay with His-tag monoclonal antibody (HRP-conjugated). (1) Proteins of interest after induction; (2) proteins of interest before induction; (3) vector after induction; (4) host cell BL21. M: Unstained protein molecular weight marker (Fermentas).](pone.0057959.g003){#pone-0057959-g003}

To confirm the immunogenicity of the identified proteins, 12 purified proteins were probed with rabbit immune serum against live spores of *B.anthracis* vaccine strain A16R. All 12 purified proteins reacted with the serum with a strong specific reactive band ([Fig. 4](#pone-0057959-g004){ref-type="fig"} A).

![Validation the immunogenicity of the 12 proteins identified by immunoproteomics.\
(A) The 12 purified proteins were probed with rabbit immune sera against live spores of *B.anthracis* vaccine strain A16R. The upper panel shows the SDS-PAGE maps of the 12 purified proteins, the middle panel is the western blotting assay with rabbit immune sera against *B.anthracis* live spores and the lower panel is the western blotting assay with the unimmunized rabbit sera. M:unstained protein molecular weight marker (Cwbio, China). (B) Western blotting assays for A16R whole cell proteins using immune sera from mice vaccinated with the 12 expressed proteins. A16R: whole cell lysate proteins of *B. anthracis* vaccine strain A16R; control: A16R whole cell proteins were probed with unimmunized mice sera. M: Unstained protein molecular weight marker (Fermentas).](pone.0057959.g004){#pone-0057959-g004}

In order to establish whether mouse polyclonal antibodies against each of the 12 recombinant proteins could react specifically with the whole cell lysate proteins of A16R, about 1 ml of the vegetative cells of A16R cultured for 23 h was harvested for SDS-PAGE. Western blot analysis was performed in which the primary antibody was the mouse immune serum against the recombinant proteins, and the second antibody was HRP-conjugated anti-mouse IgG antibody. All the mouse immune sera against recombinant proteins reacted with the lytic cell proteins of A16R with a specific reactive band, except for BA0887. The serum against protein BA0887 had several reactive bands with the lytic cell proteins of A16R, which may have been because the protein was broken into small peptides during SDS-PAGE. The results validated the immunogenicity of these proteins ([Fig. 4](#pone-0057959-g004){ref-type="fig"} B).

Computational analyses of the novel identified immunogenic protein {#s3e}
------------------------------------------------------------------

In this study, 26 *B.anthracis* immunogenic proteins were documented for the first time; 22 of which were enzymes, and the other four were general stress proteins, ribosomal proteins and DNA-binding response regulators. Cellular function analysis indicated that most of the novel immunogenic proteins were involved in amino acid transport and metabolism and energy production and conversion. The subcellular localization analysis indicated that two (BA1213 and BA0344) of the 26 proteins were cytoplasmic membrane proteins and the others were cytoplasmic proteins. Predictions of transmembrane regions with the TMpred program indicated that 16 proteins had transmembrane regions and the BA0344 protein had three transmembrane regions. Signal peptide predictions indicated that no signal peptides were present in the N-terminal 70aa of the 26 proteins ([Table S4](#pone.0057959.s004){ref-type="supplementary-material"}).

Discussion {#s4}
==========

The aim of this study was to identify the immunogenic proteins of *B.anthracis* spore and vegetative forms as candidates for the development of vaccines and inhibitors against anthrax. Spores are the dormant state of *B.anthracis* and their germination and early outgrowth are considered as targets against anthrax. Prevention of *B.anthracis* at the onset of its life cycle could suppress downstream events such as bacteremia and toxemia, which are associated with disease manifestations. Therefore, the spores, which were not only the infective form of *B.anthracis* but also the antigens that elicited a host immune response, were chosen for investigation in the present study.

Among the identified proteins, EA1, which is encoded by the *eag* gene and has been reported several times before, was found only in the vegetative proteins in the present study. EA1 protein belongs to the S-layer proteins with various functions, including shape maintenance, host evasion, cell adhesion, and resistance to phagocytosis [@pone.0057959-Ariel1], [@pone.0057959-Fouet1], [@pone.0057959-Mesnage1], [@pone.0057959-Mukhopadhyay1]. EA1 protein contains a standard signal peptide and is considered to be a major surface antigen and vaccine carrier *in vivo* [@pone.0057959-Mesnage2], [@pone.0057959-Mesnage3], [@pone.0057959-Mesnage4]. Apart from the two predominant S-layer proteins (EA1 and Sap) on pXO1 previously identified by Okinaka[@pone.0057959-Okinaka1], Mock and Fouet were the first to report that the *B.anthracis* genome harbors additional genes coding for S-layer homology (SLH) proteins that may constitute potential vaccine candidates[@pone.0057959-Ariel2], [@pone.0057959-Montigiani1]. Computational analysis of the *B.anthracis* draft version of the chromosome for ORFs containing at least one SLH domain has revealed the presence of 20 putative S-layer homology domain proteins[@pone.0057959-Ariel1]. In this study, the identified immunogenic proteins list also included a novel putative S-layer protein BA3338, which consisted of an N-terminal signal peptide for export, and three S-layer homology domains for anchorage to the cell wall. BA3338 is highly similar to internalin of *Bacillus cereus*, which is considered to be a candidate virulence factor [@pone.0057959-Fedhila1].

Recently, to understand the pathogenicity and immunogenicity of *Streptococcus iniae*, Shin [@pone.0057959-Shin2] identified that GAPDH, fructose bisphosphate and enolase have high immunogenicity. It has been reported that GAPDH (BA5369) can bind various mammalian proteins, such as lysozyme, fibronectin and cytoskeletal proteins myosin and actin[@pone.0057959-Lei1], [@pone.0057959-Len1], [@pone.0057959-Nakamura1]. Therefore, it can be concluded that GAPDH plays an important role in adhesion to host cells and their colonization. In our study, GAPDH protein was found in both the spore and vegetative proteins of *B. anthracis* A16R. This is consistent with the study of Delvecchio who has concluded that GAPDH is involved in spore germination, energy metabolism and strain growth[@pone.0057959-Delvecchio1]. Enolase (BA5364) has been previously identified as a component of Anthrax Vaccine Adsorbed and has a role in the virulence and protection of *B.anthracis* [@pone.0057959-Whiting1]. The E1 component subunit α (BA4184) of the pyruvate dehydrogenase (PDH) complex, in which another two proteins are dihydrolipoyl transacetylase (E2) and dihydrolipoyl dehydrogenase (E3), takes part in the tricarboxylic acid cycle to generate NADH, ATP, and reduced FAD [@pone.0057959-Delvecchio1], [@pone.0057959-March1] Although its function in *B.anthracis* has not been reported, the PDH complex has been shown to be highly immunogenic in other bacterial species, such as *Mycoplasma capricolum*, *Neisseria meningitidis*, and *Mycoplasma hyopneumoniae*. Recently, PDH has been tested as a DNA vaccine against *Mycoplasma mycoides subsp. mycoides*, the causal agent of contagious bovine pleuropneumonia [@pone.0057959-March1].

Translation elongation factors (Tuf and Tsf) and chaperones (DnaK and GroEL) are important core metabolic proteins that facilitate rapid growth upon germination. Additionally, alkyl hydroperoxide reductase, subunit C (BA0345), has been reported to be immunogenic in the *B.anthracis* membrane fraction [@pone.0057959-Schoeni1].

In summary, the present study investigated the immunogenic proteins of the spore and vegetative forms of *B.anthracis* vaccine strain A16R using 2-DE immunoblot assays. Forty-five and 11 immunogenic proteins were found in the vegetative and spore forms, respectively. Fifty immunogenic proteins were identified. Twenty-four of these have been reported previously and the other 26 were new immunogenic proteins found only in this study. Seven common antigenic proteins were observed on both 2-DE immunoblot profiles, whereas 38 and four proteins, respectively, were found as specific antigens for vegetative and spore forms of *B.anthracis*. Twelve proteins were selected for prokaryotic expression and antisera were made to validate their immunogenicity further. In fact, some of these immunogenic proteins might be used as novel vaccine candidates themselves, or inclusion of one or more of these newly identified immunogenic proteins in a PA-base vaccine may serve to enhance protective efficacy. Future work probing the identified immunogenic proteins with the serum from convalescent anthrax patients, and *in vivo* protection experiments, should be carried out to validate the immunogenicity and protective efficacy. The immunoproteomics approach is valuable for identifying immunogenic proteins for use in vaccine development.
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